Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24523N0499
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,196
Award facts
- Contract value 100% obligated
- $12,195.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a delivery order to Otsuka America Pharmaceutical Inc. on April 7, 2023, for the supply of Jynarque (tolvaptan) 90mg/30mg pharmaceutical products. This firm-fixed-price delivery order, valued at $12,195.72, represents a task order issued under the parent Blanket Purchase Agreement on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract does not utilize a set-aside designation and carries an ultimate completion date of April 12, 2023, with performance to be completed in Pittsburgh, Pennsylvania. Jynarque is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia, critical therapeutic agents within the VA's healthcare system for eligible veterans.
This delivery order is part of Otsuka America Pharmaceutical Inc.'s established relationship with the VA through its $83.3 million Blanket Purchase Agreement with the National Acquisition Center. The company maintains significant contract vehicles to support VA Integrated Service Networks across multiple regions, enabling streamlined procurement of specialized pharmaceutical treatments. As a pharmaceutical manufacturer headquartered in Rockville, Maryland, Otsuka America is registered in the System for Award Management and demonstrates consistent capacity to fulfill federal healthcare supply requirements across the VA's distributed medical facilities nationwide.
Quick answers
Who was awarded contract 36C24523N0499?
36C24523N0499 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 7, 2023.
How much is contract 36C24523N0499 worth?
The government has obligated $12,196 on 36C24523N0499.
Is contract 36C24523N0499 an order under another contract?
Yes. 36C24523N0499 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24523N0499 competed?
The extent of competition for 36C24523N0499 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award